Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure
Miki Imazu(National Cerebral and Cardiovascular Center), Masafumi Kitakaze(Hanwa Memorial Hospital), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Toshisuke Morita(Toho University), Osamu Tsukamoto(University of California, Los Angeles), Hiroyuki Takahama(Tohoku University), Tatsuro Hitsumoto(The University of Osaka), Takuya Hasegawa(National Cerebral and Cardiovascular Center), Shin Ito(National Cerebral and Cardiovascular Center), Makoto Amaki(National Cerebral and Cardiovascular Center), Hiroki Fukuda(National Cerebral and Cardiovascular Center)
Cited by 27
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288